Literature DB >> 12865616

Registration of stroke through the Belgian sentinel network and factors influencing stroke mortality.

Dirk Devroey1, Viviane Van Casteren, Frank Buntinx.   

Abstract

INTRODUCTION: Stroke is one of the leading causes of death. Belgian stroke mortality rates are only available from the death certificates notification.
OBJECTIVES: To estimate stroke incidence, mortality and case fatality, to compare our figures with those available from the death certificates notification and from neighboring countries, and identifying factors influencing survival.
METHODS: A nationwide prospective registration by 178 Belgian general practitioners recording all cerebrovascular events in 1998-1999. All events, including those for which medical care was immediately found in hospital, were included.
RESULTS: The yearly age-and-gender-adjusted stroke attack rates were estimated at 185 cases per 100,000 inhabitants (95% CI = 169-202). After 12 months, 47% of the patients died, resulting in an estimated yearly stroke mortality rate of 88 per 100,000 inhabitants (95% CI = 73-105). The case fatality rate among men (39%; 95% CI = 29-51) was lower than among women (50%; 95% CI = 39-63) (p < 0.05). In a forward stepwise logistic regression diabetes, stroke history, hemorrhagic stroke, coma, swallow deficit and urinary incontinence had a negative influence on stroke survival. Treated hypertension had a beneficial effect on survival.
CONCLUSIONS: Stroke mortality rates estimated by the sentinel practices are fairly comparable with those based on the death certificates notification. The stroke attack rates correspond with those of neighboring countries. The role of treated hypertension on the outcome of strokes remains controversial in this registration. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12865616     DOI: 10.1159/000071127

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  11 in total

1.  Stroke and systemic embolism prevention in patients with atrial fibrillation in Belgium: comparative cost effectiveness of new oral anticoagulants and warfarin.

Authors:  Thitima Kongnakorn; Tereza Lanitis; Lieven Annemans; Vincent Thijs; Marnix Goethals; Sophie Marbaix; Jean-Claude Wautrecht
Journal:  Clin Drug Investig       Date:  2015-02       Impact factor: 2.859

Review 2.  Sex differences in stroke.

Authors:  L Christine Turtzo; Louise D McCullough
Journal:  Cerebrovasc Dis       Date:  2008-09-23       Impact factor: 2.762

3.  Physician reports of medication use with explicit intention of hastening the end of life in the absence of explicit patient request in general practice in Belgium.

Authors:  Koen Meeussen; Lieve Van den Block; Nathalie Bossuyt; Michael Echteld; Johan Bilsen; Luc Deliens
Journal:  BMC Public Health       Date:  2010-04-09       Impact factor: 3.295

4.  Sex-related time-dependent variations in post-stroke survival--evidence of a female stroke survival advantage.

Authors:  Tom Skyhøj Olsen; Christian Dehlendorff; Klaus Kaae Andersen
Journal:  Neuroepidemiology       Date:  2007-12-13       Impact factor: 3.282

5.  GPs' awareness of patients' preference for place of death.

Authors:  Koen Meeussen; Lieve Van den Block; Nathalie Bossuyt; Johan Bilsen; Michael Echteld; Viviane Van Casteren; Luc Deliens
Journal:  Br J Gen Pract       Date:  2009-09       Impact factor: 5.386

6.  Signs for early diagnosis of heart failure in primary health care.

Authors:  Dirk Devroey; Viviane Van Casteren
Journal:  Vasc Health Risk Manag       Date:  2011-09-14

7.  Nationwide monitoring of end-of-life care via the Sentinel Network of General Practitioners in Belgium: the research protocol of the SENTI-MELC study.

Authors:  Lieve Van den Block; Viviane Van Casteren; Reginald Deschepper; Nathalie Bossuyt; Katrien Drieskens; Sabien Bauwens; Johan Bilsen; Luc Deliens
Journal:  BMC Palliat Care       Date:  2007-10-08       Impact factor: 3.234

8.  Euthanasia and other end-of-life decisions: a mortality follow-back study in Belgium.

Authors:  Lieve Van den Block; Reginald Deschepper; Johan Bilsen; Nathalie Bossuyt; Viviane Van Casteren; Luc Deliens
Journal:  BMC Public Health       Date:  2009-03-09       Impact factor: 3.295

9.  Hospitalisations at the end of life: using a sentinel surveillance network to study hospital use and associated patient, disease and healthcare factors.

Authors:  Lieve Van den Block; Reginald Deschepper; Katrien Drieskens; Sabien Bauwens; Johan Bilsen; Nathalie Bossuyt; Luc Deliens
Journal:  BMC Health Serv Res       Date:  2007-05-08       Impact factor: 2.655

10.  Cost-effectiveness of rivaroxaban versus warfarin for stroke prevention in atrial fibrillation in the Belgian healthcare setting.

Authors:  Joris Kleintjens; Xiao Li; Steven Simoens; Vincent Thijs; Marnix Goethals; Ernst R Rietzschel; Yumi Asukai; Ömer Saka; Thomas Evers; Petra Faes; Stefaan Vansieleghem; Mimi De Ruyck
Journal:  Pharmacoeconomics       Date:  2013-10       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.